Published in Gastroenterol Rep (Oxf) on February 26, 2015
Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology (2012) 3.83
Crohn's disease and cancer. N Engl J Med (1973) 2.68
Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen. Gut (1985) 2.56
Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology (1995) 2.44
Malignancy in Crohn's disease. Gut (1980) 2.33
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22
Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology (2001) 1.97
Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology (1991) 1.93
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut (1988) 1.82
Crohn's disease and cancer: a population-based cohort study. Gastroenterology (1994) 1.77
Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology (1993) 1.74
High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol (2008) 1.64
Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol (2004) 1.56
Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis. Clin Gastroenterol Hepatol (2012) 1.56
Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology (1983) 1.55
The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol (1999) 1.40
Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis (2006) 1.29
Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.29
The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology (1999) 1.05
Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with psc. J Pediatr Gastroenterol Nutr (2001) 1.01
Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. Am J Surg Pathol (2009) 0.92
Interactions between chronic liver disease and inflammatory bowel disease. Inflamm Bowel Dis (1997) 0.91
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis (2010) 0.90
Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis. Dis Colon Rectum (2011) 0.90
Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis. Clin Gastroenterol Hepatol (2011) 0.85
Comparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn's disease. Gastroenterol Rep (Oxf) (2014) 0.83
Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis. Gastrointest Endosc (2012) 0.81
Severity of primary sclerosing cholangitis and its impact on the clinical outcome of Crohn's disease. J Crohns Colitis (2012) 0.81